Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer RegistryJavier Gállego, Felipe Álvarez Manceñido, A. Viúdez et al.|British Journal of Cancer|2017Cited by 106
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registryAlberto Carmona‐Bayonas, Pilar Alfonso, Paula Jiménez‐Fonseca et al.|European Journal of Surgical Oncology|2018Cited by 60
Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumabJavier Gállego, Ana Custodio, Alberto Carmona‐Bayonas et al.|British Journal of Cancer|2017Cited by 49
Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer RegistryJavier Gállego, Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca et al.|Gastric Cancer|2017Cited by 20
Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO studyManuel Sánchez-Cánovas, Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca et al.|PLoS ONE|2023Cited by 3